Voglow GM Forte 0.2/1000/2 Tablet SR 15 is used to manage type 2 diabetes in adults when diet, exercise and dual-agent therapy do not provide adequate blood sugar control. It is a combination medicine containing glimepiride, metformin and voglibose, and belongs to the class of antidiabetic medicines.
This medicine combines glimepiride, which stimulates the pancreas to release more insulin, with metformin, which reduces glucose production in the liver, and voglibose, which slows the absorption of carbohydrates in the intestine, together providing a comprehensive approach to blood sugar control.
Continuing this medicine, even if you feel well or your blood sugar seems controlled, is essential to prevent potential complications such as kidney damage, vision loss and nerve problems.
Tell your doctor about any liver, kidney or heart problems, before starting this medicine. Recognise the signs of low blood glucose, such as sweating, dizziness, headache and shaking, and know how to manage them. Maintain regular meal times and carry a fast-acting glucose source.






































